In light of the growing demand for international pharmaceutical transportation to Latin America in the midst of COVID-19’s health crisis, LATAM Cargo has extended its pharma coverage.
This care option, which is CEIV Pharma certified, is part of the company’s product portfolio and offers specialized transportation for these sensitive and delicate shipments.
The pandemic—which is currently affecting Latin America—has triggered closed-border policies and passenger flight restrictions worldwide. This led the Latin American company into adopting various measures to modify its itinerary and strengthen its operation in order to mitigate negative effects on its clients. These reactions have allowed LATAM Cargo to maintain a constant service throughout the health crisis.
One of the most important modifications has to do with the expansion of PHARMA’s network in order to satisfy clients’ growing interest in transporting products from Europe to more Latin American markets. During the last three months, the company implemented four transit stations to expand coverage and reach currently relevant markets for its clients. These stations include Miami (USA), Santiago (Chile), Buenos Aires (Argentina) and a second entry point in Sao Paulo (Brazil).
Cristina Oñate, vice president, marketing and product development, LATAM Cargo, commented:The goods we transport with our PHARMA solutions to Latin America are delicate and extremely sensitive to temperature deviations. In order to continue satisfying our clients’s needs at such a critical time, we reacted quickly and efficiently while maintaining our product’s quality level. For each of the recently implemented routes, we have ensured that the established protocols and procedures for our care are met.”
The recently launched transit stations provide access to Puerto Rico, New Zealand, Ecuador and Paraguay and allow LATAM Cargo to offer more routes for different origins-destinations. This way, the company strengthens its coverage and provides its clients with more alternatives.